CLS-Logo-1.jpg
Toronto General Hospital Physicians Presented Interim Clinical Study Results for MR-guided FLA Treatment of Low-intermediate Risk Localized Prostate Cancer at AdMeTech 4th Global Summit
07 oct. 2019 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (CLS) today announced that Dr. Sangeet Ghai and other physicians at Toronto General Hospital presented a poster at...
CLS-Logo-1.jpg
CLS Presents Poster on “Laser Thermal Therapy for Brain Metastases” at 9th Annual Brain Mets Congress in Marseille, France
02 oct. 2019 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present a poster at the 9th Annual Brain Metastases Research and Emerging...
CLS-Logo-1.jpg
CLS Presents Poster on “Laser Thermal Therapy for Brain Metastases” at 9th Annual Brain Mets Congress in Marseille, France
02 oct. 2019 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present a poster at the 9th Annual Brain Metastases Research and Emerging...
CLS-Logo-1.jpg
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS-Logo-1.jpg
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS-Logo-1.jpg
CLS Presents Image-Guided Laser Immunotherapy System at 16th Annual Anglonordic Life Science Investor Conference
07 mai 2019 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
CEO Will Discuss New Products, Clinical Studies, and Industry Partners LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its TRANBERG® çThermal...
CLS-Logo-1.jpg
CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
08 avr. 2019 03h45 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’s imILT® immuno-stimulating method for...
CLS-Logo-1.jpg
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
25 mars 2019 03h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical studies and results for its imILT® heat-induced cancer immunotherapy for...
CLS-Logo-1.jpg
CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam
25 mars 2019 03h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will be exhibiting and presenting its High Precision, Image-Guided Laser Ablation...
CLS-Logo-1.jpg
CLS Signs Agreement with Siemens Healthineers to Secure Optimal Interfacing to the World Leading Portfolio of Magnetom MRI Scanners from Siemens Healthineers
08 janv. 2019 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) and Siemens Healthineers have signed an agreement that gives CLS the right to license...